Effectiveness and Adherence to Treatment with Perindopril/Indapamide/Amlodipine Single-Pill Combination in a Greek Population with Hypertension

Clinical Drug Investigation
Kostas TsioufisAthanasios J Manolis

Abstract

Despite the overwhelming evidence and the established benefits of antihypertensive treatment, adherence to treatment remains low. To assess the adherence to treatment with a perindopril/indapamide/amlodipine single-pill combination (SPC), its effectiveness on blood pressure (BP) reduction, as well as the safety and tolerability of this SPC over a 4-month treatment period. This multicenter, non-interventional study prospectively included 2285 hypertensive patients on perindopril/indapamide/amlodipine SPC. The data were recorded at baseline, 1 month, and 4 months. Of the 2285 hypertensive patients included in the study, 50.5% were at "high/very high risk". Mean systolic (SBP)/diastolic (DBP) decreased from 162.3 ± 13.3/93.1 ± 9.3 mmHg at baseline to 129.7 ± 8.3/78.6 ± 7.1 mmHg at 4 months (p < 0.001). Patients with higher baseline BP levels showed greater BP reduction. Patients with hypertension stages 1, 2, and 3 showed mean SBP/DBP reductions of 21.5/10.4 mmHg, 34.2/14.7 mmHg, and 51.2/22.5 mmHg, respectively, at study end (p < 0.001). Only 26 patients (1.1%) prematurely discontinued treatment (0.58% due to an adverse reaction or event). Perindopril/indapamide/amlodipine SPC decreased BP levels rapidly and significantly. The de...Continue Reading

References

Oct 27, 2001·Journal of Clinical Pharmacy and Therapeutics·E VermeireJ Denekens
Aug 7, 2007·The American Journal of Medicine·Sripal BangaloreFranz H Messerli
Jul 23, 2008·International Journal of Clinical Practice·N ChungT Fujita
Jan 23, 2010·European Heart Journal·Christopher B Granger, Bernhard J Gersh
Jul 6, 2010·Preventive Medicine·Alberto J Caban-MartinezDavid J Lee
Dec 16, 2010·Journal of Hypertension·Giovanni CorraoGiuseppe Mancia
Feb 8, 2011·The American Journal of Medicine·Harikrishna MakaniFranz H Messerli
Mar 4, 2011·The Journal of Clinical Hypertension·Alan H GradmanUNKNOWN American Society of Hypertension Writing Group
Aug 13, 2011·American Heart Journal·James B ByrdP Michael Ho
Jun 14, 2013·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Ulrich Kintscher
Jun 12, 2013·Hypertension·Michel BurnierJohn Urquhart
Mar 15, 2015·Circulation Research·Alberto ZanchettiGianfranco Parati
Apr 3, 2015·Lancet·Neil R PoulterMark Caulfield
Jul 6, 2016·Journal of Advanced Nursing·Ali Hussein Al-GanmiAbdulellah Modhi Alotaibi
Nov 30, 2016·Journal of Hypertension·Giuseppe ManciaGiovanni Corrao
Mar 18, 2017·Journal of Hypertension·Idir HamdidoucheStéphane Laurent
Apr 23, 2017·Drugs & Aging·Paola H Ponte MárquezUNKNOWN Potentially Inappropriate Prescription in Older Patients in Spain (PIPOPS) Investigators’ Project
Aug 3, 2017·Clinical Medicine : Journal of the Royal College of Physicians of London·Linsay McCallum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.